LOCUS       NM_001018055            2877 bp    mRNA    linear   PRI 09-SEP-2011
DEFINITION  Homo sapiens BRCA1/BRCA2-containing complex, subunit 3 (BRCC3),
            transcript variant 2, mRNA.
ACCESSION   NM_001018055
VERSION     NM_001018055.2  GI:336285484
KEYWORDS    .
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 2877)
  AUTHORS   Miskinyte,S., Butler,M.G., Herve,D., Sarret,C., Nicolino,M.,
            Petralia,J.D., Bergametti,F., Arnould,M., Pham,V.N., Gore,A.V.,
            Spengos,K., Gazal,S., Woimant,F., Steinberg,G.K., Weinstein,B.M.
            and Tournier-Lasserve,E.
  TITLE     Loss of BRCC3 deubiquitinating enzyme leads to abnormal
            angiogenesis and is associated with syndromic moyamoya
  JOURNAL   Am. J. Hum. Genet. 88 (6), 718-728 (2011)
   PUBMED   21596366
  REMARK    GeneRIF: these data strongly suggest that BRCC3, a deubiquitinating
            enzyme that is part of the cellular BRCA1 and BRISC complexes, is
            an important player in angiogenesis and that BRCC3 loss-of-function
            mutations are associated with moyamoya angiopathy.
REFERENCE   2  (bases 1 to 2877)
  AUTHORS   Coleman,K.A. and Greenberg,R.A.
  TITLE     The BRCA1-RAP80 complex regulates DNA repair mechanism utilization
            by restricting end resection
  JOURNAL   J. Biol. Chem. 286 (15), 13669-13680 (2011)
   PUBMED   21335604
REFERENCE   3  (bases 1 to 2877)
  AUTHORS   Hu,X., Kim,J.A., Castillo,A., Huang,M., Liu,J. and Wang,B.
  TITLE     NBA1/MERIT40 and BRE interaction is required for the integrity of
            two distinct deubiquitinating enzyme BRCC36-containing complexes
  JOURNAL   J. Biol. Chem. 286 (13), 11734-11745 (2011)
   PUBMED   21282113
  REMARK    GeneRIF: NBA1/MERIT40 and BRE interaction is required for the
            integrity of two distinct deubiquitinating enzyme BRCC36-containing
            complexes
REFERENCE   4  (bases 1 to 2877)
  AUTHORS   Feng,L., Wang,J. and Chen,J.
  TITLE     The Lys63-specific deubiquitinating enzyme BRCC36 is regulated by
            two scaffold proteins localizing in different subcellular
            compartments
  JOURNAL   J. Biol. Chem. 285 (40), 30982-30988 (2010)
   PUBMED   20656690
  REMARK    GeneRIF: scaffold proteins not only participate in the regulation
            of BRCC36 activity but also determine its subcellular localization
            and cellular functions.
REFERENCE   5  (bases 1 to 2877)
  AUTHORS   Cooper,E.M., Boeke,J.D. and Cohen,R.E.
  TITLE     Specificity of the BRISC deubiquitinating enzyme is not due to
            selective binding to Lys63-linked polyubiquitin
  JOURNAL   J. Biol. Chem. 285 (14), 10344-10352 (2010)
   PUBMED   20032457
REFERENCE   6  (bases 1 to 2877)
  AUTHORS   Shao,G., Lilli,D.R., Patterson-Fortin,J., Coleman,K.A.,
            Morrissey,D.E. and Greenberg,R.A.
  TITLE     The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes
            RNF8-Ubc13-dependent ubiquitination events at DNA double strand
            breaks
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 106 (9), 3166-3171 (2009)
   PUBMED   19202061
REFERENCE   7  (bases 1 to 2877)
  AUTHORS   Boudreau,H.E., Broustas,C.G., Gokhale,P.C., Kumar,D., Mewani,R.R.,
            Rone,J.D., Haddad,B.R. and Kasid,U.
  TITLE     Expression of BRCC3, a novel cell cycle regulated molecule, is
            associated with increased phospho-ERK and cell proliferation
  JOURNAL   Int. J. Mol. Med. 19 (1), 29-39 (2007)
   PUBMED   17143545
  REMARK    GeneRIF: These findings demonstrate that BRCC3 is a novel effector
            of Raf-1, and implicate a role of BRCC3 in modulation of p-ERK,
            cell survival and proliferation.
REFERENCE   8  (bases 1 to 2877)
  AUTHORS   Dong,Y., Hakimi,M.A., Chen,X., Kumaraswamy,E., Cooch,N.S.,
            Godwin,A.K. and Shiekhattar,R.
  TITLE     Regulation of BRCC, a holoenzyme complex containing BRCA1 and
            BRCA2, by a signalosome-like subunit and its role in DNA repair
  JOURNAL   Mol. Cell 12 (5), 1087-1099 (2003)
   PUBMED   14636569
REFERENCE   9  (bases 1 to 2877)
  AUTHORS   Fisch,P., Forster,A., Sherrington,P.D., Dyer,M.J. and Rabbitts,T.H.
  TITLE     The chromosomal translocation t(X;14)(q28;q11) in T-cell
            pro-lymphocytic leukaemia breaks within one gene and activates
            another
  JOURNAL   Oncogene 8 (12), 3271-3276 (1993)
   PUBMED   8247530
REFERENCE   10 (bases 1 to 2877)
  AUTHORS   Kenwrick,S., Levinson,B., Taylor,S., Shapiro,A. and Gitschier,J.
  TITLE     Isolation and sequence of two genes associated with a CpG island 5'
            of the factor VIII gene
  JOURNAL   Hum. Mol. Genet. 1 (3), 179-186 (1992)
   PUBMED   1303175
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from BP304352.1, X64643.1,
            BX293995.4 and BC002999.1.
            On Jun 17, 2011 this sequence version replaced gi:64762483.
            
            Summary: This gene encodes a subunit of the BRCA1-BRCA2-containing
            complex (BRCC), which is an E3 ubiquitin ligase. This complex plays
            a role in the DNA damage response, where it is responsible for the
            stable accumulation of BRCA1 at DNA break sites. The component
            encoded by this gene can specifically cleave Lys 63-linked
            polyubiquitin chains, and it regulates the abundance of these
            polyubiquitin chains in chromatin. The loss of this gene results in
            abnormal angiogenesis and is associated with syndromic moyamoya, a
            cerebrovascular angiopathy. Alternative splicing results in
            multiple transcript variants. A related pseudogene has been
            identified on chromosome 5. [provided by RefSeq, Jun 2011].
            
            Transcript Variant: This variant (2) lacks an alternate in-frame
            exon in the central coding region, compared to variant 1, resulting
            in an isoform (2) that is shorter than isoform 1.
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            COMPLETENESS: complete on the 3' end.
PRIMARY     REFSEQ_SPAN         PRIMARY_IDENTIFIER PRIMARY_SPAN        COMP
            1-102               BP304352.1         1-102
            103-1844            X64643.1           1-1742
            1845-2839           BX293995.4         66759-67753         c
            2840-2877           BC002999.1         2809-2846
FEATURES             Location/Qualifiers
     source          1..2877
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="X"
                     /map="Xq28"
     gene            1..2877
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
                     /note="BRCA1/BRCA2-containing complex, subunit 3"
                     /db_xref="GeneID:79184"
                     /db_xref="HGNC:24185"
                     /db_xref="MIM:300617"
     exon            1..231
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
                     /inference="alignment:Splign:1.39.8"
                     /number=1
     CDS             109..984
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
                     /EC_number="3.1.2.15"
                     /note="isoform 2 is encoded by transcript variant 2;
                     lys-63-specific deubiquitinase BRCC36;
                     BRCA1/BRCA2-containing complex subunit 36; BRISC complex
                     subunit BRCC36; BRCA1-A complex subunit BRCC36"
                     /codon_start=1
                     /product="lys-63-specific deubiquitinase BRCC36 isoform 2"
                     /protein_id="NP_001018065.1"
                     /db_xref="GI:64762484"
                     /db_xref="CCDS:CCDS56612.1"
                     /db_xref="GeneID:79184"
                     /db_xref="HGNC:24185"
                     /db_xref="MIM:300617"
                     /translation="MAVQVVQAVQAVHLESDAFLVCLNHALSTEKEEVMGLCIGELND
                     DTRSDSKFAYTGTEMRTVAEKVDAVRIVHIHSVIILRRSDKRKDRVEISPEQLSAAST
                     EAERLAELTGRPMRVVGWYHSHPHITVWPSHVDVRTQAMYQMMDQGFVGLIFSCFIED
                     KNTKTGRVLYTCFQSIQAQKSSEYERIEIPIHIVPHVTIGKVCLESAVELPKILCQEE
                     QDAYRRIHSLTHLDSVTKIHNGSVFTKNLCSQMSAVSGPLLQWLEDRLEQNQQHLQEL
                     QQEKEELMQELSSLE"
     STS             168..315
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
                     /standard_name="STS-X64643"
                     /db_xref="UniSTS:35369"
     exon            232..248
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
                     /inference="alignment:Splign:1.39.8"
                     /number=2
     exon            249..303
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
                     /inference="alignment:Splign:1.39.8"
                     /number=3b
     exon            304..423
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
                     /inference="alignment:Splign:1.39.8"
                     /number=4
     exon            424..511
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
                     /inference="alignment:Splign:1.39.8"
                     /number=5
     exon            512..600
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
                     /inference="alignment:Splign:1.39.8"
                     /number=6
     exon            601..656
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
                     /inference="alignment:Splign:1.39.8"
                     /number=7
     exon            657..788
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
                     /inference="alignment:Splign:1.39.8"
                     /number=9
     exon            789..832
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
                     /inference="alignment:Splign:1.39.8"
                     /number=10
     exon            833..1002
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
                     /inference="alignment:Splign:1.39.8"
                     /number=11
     exon            1003..2853
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
                     /inference="alignment:Splign:1.39.8"
                     /number=12
     STS             2267..2447
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
                     /standard_name="RH79163"
                     /db_xref="UniSTS:87186"
     polyA_signal    2827..2832
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
     polyA_site      2854
                     /gene="BRCC3"
                     /gene_synonym="BRCC36; C6.1A; CXorf53; RP11-143H17.2"
ORIGIN      
        1 aggcctgggc ggagcgcaca gcgctgggcg ctggggaggc tgcgccgcag cacccggttg
       61 gtcaggacca agtgggcccg aggcggacgt gagaagggtc gggccaagat ggcggtgcag
      121 gtggtgcagg cggtgcaggc ggttcatctc gagtctgacg ctttcctcgt ttgtctcaac
      181 cacgctctga gcacagagaa ggaggaagta atggggctgt gcatagggga gttgaacgat
      241 gatacaagga gtgactccaa atttgcatat actggaactg aaatgcgcac agttgctgaa
      301 aaggttgatg ccgtcagaat tgttcacatt cattctgtca tcatcttacg acgttctgat
      361 aagaggaagg accgagtaga aatttctcca gagcagctgt ctgcagcttc aacagaggca
      421 gagaggttgg ctgaactgac aggccgcccc atgagagttg tgggctggta tcattcccat
      481 cctcatataa ctgtttggcc ttcacatgtt gatgttcgca cacaagccat gtaccagatg
      541 atggatcaag gctttgtagg acttattttt tcctgtttca tagaagataa gaacacaaag
      601 actggccggg tactctacac ttgcttccaa tccatacagg cccaaaagag ttcagagtat
      661 gagagaatcg aaatcccaat ccatattgta cctcatgtca ctatcgggaa agtgtgcctt
      721 gaatcagcag tagagctgcc caagatcctg tgccaggagg agcaggatgc gtataggagg
      781 atccacagcc ttacacatct ggactcagta accaagatcc ataatggctc agtgtttacc
      841 aagaatctgt gcagtcagat gtcggcagtc agcgggcctc tcctacagtg gttggaggac
      901 agactggagc aaaaccaaca gcatttgcag gaattacaac aagaaaagga agagcttatg
      961 caagaacttt cttctctaga ataaatcagg agacaaaatg gggaaagatg aaaatatcca
     1021 gtgtaaagtt acttaagcta aatcaatttc aaagaagaaa aacttggagg actcatttta
     1081 cctgacttca agacttacta taaagctata gtaatcaaga tagatggtat tggcagagga
     1141 acagacacat acgtcaatgg aacagatgag agaacccaga aataaaccca tataaatatg
     1201 ctcagctgat tttgaaaaag tgaaaaagca attcaatgga ggaagaatag cctttctgac
     1261 aaattatgct agagcaatta gacacccatg gcgaggagaa aaaagaacct ctacttaaac
     1321 ctcacatctt atataaaatt taactcaaaa tgtataacgg acttaaatgt gatacataaa
     1381 actagataac tttgaaaaaa gccacaggag aaaaatcttc aggatcttgg gctaggtgac
     1441 aagttcttgg actttgcccc gaaagcacat ccataaaaga caaaatctga tatattggac
     1501 ttcttcaaaa tttaaaaact tgtgatttaa gaagaggaaa agataagcta cagattgaga
     1561 tgaatttgca aaccatatat ctgatcaatt tggaatatat aaagtgtact aaaaactcaa
     1621 ctgaagtcag gcatggtagc tcatgcttgt aatctcacca ctttgggagg ccaagatggg
     1681 aggagtgctt gaggttaggc gttccagacc agcctgggca acatagtgag actcttgtct
     1741 ctacaaaaag tttttttaaa aaattaactg ggcaccatga cacacaccag tagtcccagc
     1801 tactagggag gcaggaggat cacttgagcc caggagtttg aggctgcggt gagctgtgat
     1861 cacaccacca cactccaacc tgtgtaacag agtgaggcct catctcaaaa aaaaaaaaag
     1921 gccacaaaac tcaacaataa aaacaaacag tccaattaga aaatgggcaa aagacatgaa
     1981 tagatgtttc actgaagagg atctatagat ggcaagtaag catatgaaaa gctgttaaac
     2041 tccataagtc atcagggaat gcaaattgaa accacagcga ggctatgact tacttatctc
     2101 aatggctaaa gaaaaaatag tgaaaatacc aaatactgat gaggatacaa actggatatt
     2161 ttatacattg ctgacaggaa tgtaaaatgg tacagccact ctgggaaaga gtttatgaat
     2221 ttcttatcaa gttaaacata attttttaat caagttaaac ataagaccca gcagttgtgc
     2281 tcctggacat tcattccaga gaaatgaaaa cctatattgt acttgtactc aaatattcat
     2341 aggagcttta tttgtaatag ccccaaactg gaaacaaccc agatgtccta caacaggtac
     2401 atggttaaac aaaccatcca taacttggaa tactgctctg gaatgaaaag gaactaactg
     2461 ttgatacaag aacttggttg tacctcaggg gtattatggt gaacaaaaaa aaaaccagtc
     2521 tcaaatggtc acatactgta tgatcgcatt tatataacat tcttgaggtg acaaaattat
     2581 tgaaatgaag aacagattaa tggttgccag ggatagggac tggagggggt gtggggtatg
     2641 tatgactata aagggatgac gcaaggagtt cctttgtgct gatggaacag ttctatatga
     2701 ttatgatgat tacgatgttg attataacat ttgattatga ggttaagcac atgagtcttt
     2761 acctgtgctg aagttgtatg gacctacata cacacaaatg aatgcatgta aaatctggtg
     2821 atactgaata aagtctgtgg tctagatagc agtaaaaaaa aaaaaaaaaa aaaaaaa
//

